Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 04 07 2019
revised: 25 07 2019
accepted: 21 08 2019
pubmed: 11 9 2019
medline: 21 10 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

Inflammation is an important driver of hypertension. Periodontitis is a chronic inflammatory disease, which could provide a mechanism for pro-hypertensive immune activation, but evidence of a causal relationship in humans is scarce. We aimed to investigate the nature of the association between periodontitis and hypertension. We performed a two-sample Mendelian randomization analysis in the ∼750 000 UK-Biobank/International Consortium of Blood Pressure-Genome-Wide Association Studies participants using single nucleotide polymorphisms (SNPs) in SIGLEC5, DEFA1A3, MTND1P5, and LOC107984137 loci GWAS-linked to periodontitis, to ascertain their effect on blood pressure (BP) estimates. This demonstrated a significant relationship between periodontitis-linked SNPs and BP phenotypes. We then performed a randomized intervention trial on the effects of treatment of periodontitis on BP. One hundred and one hypertensive patients with moderate/severe periodontitis were randomized to intensive periodontal treatment (IPT; sub- and supragingival scaling/chlorhexidine; n = 50) or control periodontal treatment (CPT; supragingival scaling; n = 51) with mean ambulatory 24-h (ABPM) systolic BP (SBP) as primary outcome. Intensive periodontal treatment improved periodontal status at 2 months, compared to CPT. This was accompanied by a substantial reduction in mean SBP in IPT compared to the CPT (mean difference of -11.1 mmHg; 95% CI 6.5-15.8; P < 0.001). Systolic BP reduction was correlated to periodontal status improvement. Diastolic BP and endothelial function (flow-mediated dilatation) were also improved by IPT. These cardiovascular changes were accompanied by reductions in circulating IFN-γ and IL-6 as well as activated (CD38+) and immunosenescent (CD57+CD28null) CD8+T cells, previously implicated in hypertension. A causal relationship between periodontitis and BP was observed providing proof of concept for development of clinical trial in a large cohort of hypertensive patients. ClinicalTrials.gov: NCT02131922.

Identifiants

pubmed: 31504461
pii: 5556904
doi: 10.1093/eurheartj/ehz646
pmc: PMC6837161
doi:

Banques de données

ClinicalTrials.gov
['NCT02131922']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3459-3470

Subventions

Organisme : British Heart Foundation
ID : FS/12/82/29736
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/13/5/30177
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/M009203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9521010
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_14089
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Hypertension. 2010 Feb;55(2):500-7
pubmed: 20038749
Arch Med Sci. 2017 Feb 1;13(1):66-74
pubmed: 28144257
Physiol Rep. 2015 Oct;3(10):
pubmed: 26486161
Basic Res Cardiol. 2013 Nov;108(6):386
pubmed: 24061433
Lancet. 2010 Dec 4;376(9756):1903-9
pubmed: 21093036
J Periodontol. 2007 Jul;78 Suppl 7S:1387-1399
pubmed: 29539084
Eur Heart J. 2019 Apr 7;40(14):1138-1145
pubmed: 30561631
Eur Heart J. 2019 Apr 7;40(14):1146-1148
pubmed: 30770702
J Periodontol. 2017 Aug;88(8):711-722
pubmed: 28452620
Clin Immunol. 2018 Sep;194:26-33
pubmed: 29936303
Br J Pharmacol. 2019 Jun;176(12):1922-1931
pubmed: 30414380
BMJ. 2018 Jul 12;362:k601
pubmed: 30002074
Eur J Prev Cardiol. 2019 May;26(8):824-835
pubmed: 30739508
Hum Mol Genet. 2018 Mar 1;27(5):941-942
pubmed: 29346566
Psychol Methods. 2010 Dec;15(4):309-34
pubmed: 20954780
J Periodontol. 2012 Dec;83(12):1449-54
pubmed: 22420873
J Exp Med. 2018 Jan 2;215(1):21-33
pubmed: 29247045
Lancet Diabetes Endocrinol. 2018 Dec;6(12):954-965
pubmed: 30472992
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
Hum Mol Genet. 2010 Feb 1;19(3):553-62
pubmed: 19897590
Cardiovasc Res. 2020 Jan 1;116(1):28-39
pubmed: 31549149
Eur J Hum Genet. 2019 Jan;27(1):102-113
pubmed: 30218097
J Clin Periodontol. 2015 Nov;42(11):988-97
pubmed: 26472626
Nat Genet. 2018 May;50(5):693-698
pubmed: 29686387
J Hum Hypertens. 2005 Jan;19(1):77-82
pubmed: 15361888
Pol Arch Med Wewn. 2013;123(9):443-52
pubmed: 24025637
Hypertension. 2013 Jul;62(1):126-33
pubmed: 23716586
J Clin Periodontol. 2017 May;44(5):456-462
pubmed: 28419559
Am J Hypertens. 2002 Feb;15(2 Pt 2):38S-42S
pubmed: 11866227
Hypertension. 2018 Dec;72(6):1365-1373
pubmed: 30540406
N Engl J Med. 2007 Mar 1;356(9):911-20
pubmed: 17329698
J Dent Res. 2019 Jun;98(6):632-641
pubmed: 31107142
Int J Epidemiol. 2017 Dec 1;46(6):1734-1739
pubmed: 28398548
Nat Rev Immunol. 2019 Aug;19(8):517-532
pubmed: 30992524
Eur Heart J. 2007 Jun;28(12):1462-536
pubmed: 17562668
Cardiovasc Res. 2017 Jul 1;113(9):1009-1023
pubmed: 28838042
Lupus. 2016 Jan;25(1):18-27
pubmed: 26251402
Atherosclerosis. 2010 Jan;208(1):258-63
pubmed: 19646696
J Am Soc Hypertens. 2014 Sep;8(9):614-23
pubmed: 25224864
Cardiovasc Res. 2018 Sep 1;114(11):1547-1563
pubmed: 29800237
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Nat Genet. 2018 Oct;50(10):1412-1425
pubmed: 30224653
J Exp Med. 2007 Oct 1;204(10):2449-60
pubmed: 17875676
Free Radic Biol Med. 2018 Sep;125:104-115
pubmed: 29857140
Hypertension. 2016 Jul;68(1):123-32
pubmed: 27217403
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1313-9
pubmed: 23520167

Auteurs

Marta Czesnikiewicz-Guzik (M)

Department of Periodontology and Oral Sciences Research Group, University of Glasgow Dental School, Glasgow, UK.
Department of Dental Prophylaxis and Experimental Dentistry, Jagiellonian University Medical College, Krakow, 31-107 Poland.

Grzegorz Osmenda (G)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.

Mateusz Siedlinski (M)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Richard Nosalski (R)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Piotr Pelka (P)

Department of Dental Prophylaxis and Experimental Dentistry, Jagiellonian University Medical College, Krakow, 31-107 Poland.

Daniel Nowakowski (D)

Department of Dental Prophylaxis and Experimental Dentistry, Jagiellonian University Medical College, Krakow, 31-107 Poland.

Grzegorz Wilk (G)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.

Tomasz P Mikolajczyk (TP)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.

Agata Schramm-Luc (A)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.

Aneta Furtak (A)

Department of Dental Prophylaxis and Experimental Dentistry, Jagiellonian University Medical College, Krakow, 31-107 Poland.

Pawel Matusik (P)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.

Joanna Koziol (J)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.

Miroslaw Drozdz (M)

St. Anna's Hospital, 32-200 Miechow, Poland.

Eva Munoz-Aguilera (E)

Periodontology Unit, UCL Eastman Dental Institute, London, UK.

Maciej Tomaszewski (M)

Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK.

Evangelos Evangelou (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.

Mark Caulfield (M)

William Harvey Research Institute, NIHR Biomedical Research Centre at Barts, Queen Mary University of London, London, UK.

Tomasz Grodzicki (T)

Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, 31-107 Krakow, Poland.

Francesco D'Aiuto (F)

Periodontology Unit, UCL Eastman Dental Institute, London, UK.

Tomasz J Guzik (TJ)

Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, 31-107, Krakow, Poland.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH